Table 3.
Multivariate analysis of clinicopathological parameters with the overall survival of patients with ovarian cancer
| Clinicopathological parameters | Cumulative survival | Relapse-free survival | ||
|---|---|---|---|---|
| Relative risk (95 % CI) | P-value | Relative risk (95 % CI) | P-value | |
| Age (≥56 years) | 1.926 (0.916–4.050) | 0.084 | 1.784 (0.963–3.306) | 0.066 |
| Pathological subtypes (serous carcinoma) | 0.854 (0.329–2.221) | 0.747 | 0.731 (0.329–1.625) | 0.442 |
| FIGO staging (III–IV) | 2.762 (1.058–7.214) | 0.038 | 1.619 (0.745–3.520) | 0.224 |
| Differentiation degree (poor) | 3.007 (1.350–6.700) | 0.007 | 1.892 (0.988–3.622) | 0.054 |
| REG4 expression (+ to +++) | 3.057 (1.369–6.827) | 0.006 | 2.282 (1.189–4.380) | 0.013 |
| Remnant foci size (≥1 cm) | 2.343 (0.995–5.519) | 0.051 | 1.834 (0.869–3.872) | 0.112 |
| Serum CA-125 level (≥500) | 0.813 (0.402–1.645) | 0.564 | 1.004 (0.556–1.812) | 0.989 |
Abbreviation: CI = confidence interval
P < 0.05, which were pointed out by bold text, indicate statistically significant